4993-93-5

Basic information

• Product Name: ETHYL 4-NITRO-1H-INDOLE-2-CARBOXYLATE
• Synonyms: ETHYL 4-NITRO-1H-INDOLE-2-CARBOXYLATE;ETHYL 4-NITROINDOLE-2-CARBOXYLATE;4-nitro-1H-indole-2-carboxylic acid ethyl ester;4-Nitro-indole-2-carboxylic acid ethyl ester
• CAS NO: 4993-93-5
• Molecular Formula: C₁₁H₁₀N₂O₄
• Molecular Weight: 234.21
• Mol File: 4993-93-5.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 429.5°Cat760mmHg
• Flash Point: 213.5°C
• Appearance: Yellow/Solid
• Density: 1.393g/cm³
• Vapor Pressure: 1.4E-07mmHg at 25°C
• Refractive Index: 1.652
• Storage Temp.: 2-8°C
• CAS DataBase Reference: ETHYL 4-NITRO-1H-INDOLE-2-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 4-NITRO-1H-INDOLE-2-CARBOXYLATE(4993-93-5)
• EPA Substance Registry System: ETHYL 4-NITRO-1H-INDOLE-2-CARBOXYLATE(4993-93-5)

Safety Data

• Hazardous Substances Data: 4993-93-5(Hazardous Substances Data)

Usage

General Description

Ethyl 4-nitro-1H-indole-2-carboxylate, also known as ethyl 4-nitroindole-2-carboxylate, is a chemical compound with the molecular formula C13H10N2O4. It is a nitro-substituted indole derivative, commonly used as a building block in the synthesis of various pharmaceuticals and agrochemicals. The compound has a yellow crystalline appearance and is insoluble in water but soluble in organic solvents. It is important to handle ethyl 4-nitro-1H-indole-2-carboxylate with caution, as it is considered to be a hazardous chemical with potential health and environmental hazards.

InChI:InChI=1/C11H10N2O4/c1-2-17-11(14)9-6-7-8(12-9)4-3-5-10(7)13(15)16/h3-6,12H,2H2,1H3

Upstream product

• 51516-96-2 3-nitrophenylhydrazine hydrochloride 
• 99-09-2 3-nitro-aniline 
• 606-20-2 2,6-dinitrotoluene 
• 1388183-69-4 ethyl 1-hydroxy-4-nitroindole-2-carboxylate 
• 851786-38-4 ethyl 3-(2,6-dinitrophenyl)pyruvate 
• 1056933-72-2 (E)-ethyl 2-(2-(3-nitrophenyl)hydrazono)propanoate 
• 134747-25-4 ethyl 2-[2-(3-nitrophenyl)hydrazinylidene]propanoate 

Downstream Products

• 120975-30-6 4-nitro-1H-indole-2-carbonitrile 
• 16732-60-8 4-nitro-1H-indole-2-carboxylic acid 
• 10242-00-9 6-Nitro-1H-indole-2-carboxylic Acid 
• 102308-53-2 6-amino-2-methylindole 
• 1221418-54-7 2-[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]-4-nitro-1H-indole 
• 1221418-52-5 2-[5-(4-fluorocinnamyl)-1,3,4-oxadiazol-2-yl]-4-nitro-1H-indole 
• 1221418-51-4 2-[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]-4-nitro-1H-indole 
• 220677-29-2 Ethyl N-(3,4-dichlorobenzyl)-4-nitroindole-2-carboxylate 
• 4769-97-5 4-nitro-1H-indoIe 
• 91119-15-2 ethyl 4-amino-1-methyl-2-indolecarboxylate 
• 110314-42-6 5-<(1H-benzofuran-2-ylcarbonyl)amino>-1H-indole-2-carboxylic acid 
• 112089-99-3 Methanesulfonic acid 3-{5-[(5-benzoylamino-1H-indole-2-carbonyl)-amino]-1H-indole-2-carbonyl}-5-benzyloxy-8-methyl-1,2,3,6-tetrahydro-pyrrolo[3,2-e]indol-1-ylmethyl ester 
• 112089-98-2 Methanesulfonic acid 5-benzyloxy-8-methyl-3-{5-[(5-ureido-1H-indole-2-carbonyl)-amino]-1H-indole-2-carbonyl}-1,2,3,6-tetrahydro-pyrrolo[3,2-e]indol-1-ylmethyl ester 
• 101134-52-5 5-Benzoylamino-1H-indole-2-carboxylic acid [2-(5-benzyloxy-1-hydroxymethyl-8-methyl-1,6-dihydro-2H-pyrrolo[3,2-e]indole-3-carbonyl)-1H-indol-5-yl]-amide 

Relevant articles and documents

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

Expedient synthesis of 1-hydroxy-4- and 1-hydroxy-6-nitroindoles

Reaction of -chloroalkyl ketones with 1,3-dinitrobenzenes provides 2,4-dinitrobenzyl ketones which when reduced with tin(II) chloride form 6-nitro derivatives of 1-hydroxyindoles. An alternative approach is the condensation of 2,4- and 2,6-dinitrotoluenes

Modulators of ATP-binding cassette transporters

Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.